Yoko Fujii‐Nishimura

456 citations
14 papers · 327 indexed · h-index 9
Topics
Pancreatic and Hepatic Oncology Research (8 papers)Neuroendocrine Tumor Research Advances (4 papers)Cancer Genomics and Diagnostics (3 papers)
Partner nations
Japan

In The Last Decade

Yoko Fujii‐Nishimura

14 papers receiving 327 citations

Peers

Yoko Fujii‐Nishimura
Comparison fields: 5 of 56
  • Oncology 230
  • Cancer Research 116
  • Pulmonary and Respiratory Medicine 68
  • Molecular Biology 65
  • Surgery 57
Replace Yiyi Liang with:
Yiyi Liang China
Cornelia Schuster Norway
Susanne Raulefs Germany
S. Zúñiga Spain
Guichuan Lai China
Lisa Hoenicke Germany
Songhui Zhao China
Ruqian Lyu Australia
Yoko Fujii‐Nishimura relative to Yiyi Liang China Yiyi Liang's profile →
Citations per field
00.5×4.8×
Yiyi Liang · 1×
Citations per year

Countries citing papers authored by Yoko Fujii‐Nishimura

Since Specialization
Citations

This map shows the geographic impact of Yoko Fujii‐Nishimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoko Fujii‐Nishimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoko Fujii‐Nishimura more than expected).

Fields of papers citing papers by Yoko Fujii‐Nishimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoko Fujii‐Nishimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoko Fujii‐Nishimura. The network helps show where Yoko Fujii‐Nishimura may publish in the future.

Co-authorship network of co-authors of Yoko Fujii‐Nishimura

This figure shows the co-authorship network connecting the top 25 collaborators of Yoko Fujii‐Nishimura. A scholar is included among the top collaborators of Yoko Fujii‐Nishimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoko Fujii‐Nishimura. Yoko Fujii‐Nishimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 11
2 72
3 10
4 73
5 1
6 27
7 7
8 77
9 7
10 12
11 10
12 1
13 12
14 7

About Yoko Fujii‐Nishimura

Yoko Fujii‐Nishimura is a scholar working on Oncology, Cancer Research and Epidemiology, having authored 14 papers that have together received 327 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (8 papers), Neuroendocrine Tumor Research Advances (4 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Oncology (230 citations), Cancer Research (116 citations) and Immunology (56 citations). Yoko Fujii‐Nishimura has collaborated with scholars based in Japan. Frequent co-authors include Minoru Kitago, Michiie Sakamoto, Yohei Masugi, Yuko Kitagawa, Masahiro Shinoda, Akihisa Ueno, Tokiya Abe, Hiroshi Yagi, Yusuke Fujita and Yutaka Endo. Their work appears in journals such as Clinical Cancer Research, British Journal of Cancer and World Journal of Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026